|
|
|
|
| LEADER |
02837nmm a2200301 u 4500 |
| 001 |
EB001898306 |
| 003 |
EBX01000000000000001061305 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
200706 ||| eng |
| 020 |
|
|
|a 9789811527241
|
| 100 |
1 |
|
|a Babar, Zaheer-Ud-Din
|e [editor]
|
| 245 |
0 |
0 |
|a Global Pharmaceutical Policy
|h Elektronische Ressource
|c edited by Zaheer-Ud-Din Babar
|
| 250 |
|
|
|a 1st ed. 2020
|
| 260 |
|
|
|a Singapore
|b Springer Nature Singapore
|c 2020, 2020
|
| 300 |
|
|
|a XVIII, 365 p. 14 illus
|b online resource
|
| 505 |
0 |
|
|a 1 Medicines Safety in the Gloablized Context -- 2 Managing the Pharmaceutical Supply Chain – To Sustainability and Beyond -- 3 Generic Medicines and Biosimilars: Impact on Global Pharmaceutical Policy -- 4 Global Access to Cancer Medicines -- 5 Medicines Pricing: Limitations of Existing Policies and New Models -- 6 Pharmacy Practice and Policy Research in Pakistan: A Review of Literature Between 2014-2019 -- 7 Promoting Access to Cancer Medicines in Mexico: Seguro Popular Key Policy Components -- 8 Access to Medicines: Case Studies from Lmics (Russia and Kyrgyzstan) -- 9 Access and Use of Medicines in Ukraine -- 10 Public Participation in Access to Medicines -- 11 Pharmaceutical Policy and Practice: A Review of Synthesis and Studies in China -- 12 Access to Vaccines and Immunization Programme -- 13. Global Antibiotics Use and Resistance -- 14 Medicines Access, Use and Pharmaceutical Health System Issues: Reflections, Thoughts and Points to Consider
|
| 653 |
|
|
|a Medical Sociology
|
| 653 |
|
|
|a Social medicine
|
| 653 |
|
|
|a Sociology
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Health Policy
|
| 653 |
|
|
|a Medical policy
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-981-15-2724-1?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 301
|
| 520 |
|
|
|a Medicines are vital in improving patient health outcomes and pharmaceutical policy is a fundamental component of any health system. However, the global pharmaceutical policy is ever-evolving and data and quality ‘research-based information’ in this field are scarce. This book fills this gap and provides up-to-date empirical information and evidence-based synthesis. It focuses on pertinent key issues in global pharmaceutical policy including medicines safety, generic medicines, pharmaceutical supply chain, medicines financing, access and affordability of medicines, rational use of medicines, pharmacy health services research and access to vaccines and biological products. Featuring policy case studies from varied countries such as Mexico, Russia, China, Kyrgyzstan, and Pakistan, this book comprises a valuable and comprehensive resource for students, funders, policymakers, academics, and researchers interested in this field
|